Abterra Biosciences (formerly Digital Proteomics) is a company engaged in antibody discovery and sequencing using NGS (next-generation sequencing) and mass spectrometry. It offers Alicanto, a digital proteomics antibody discovery platform that identifies target-specific antibodies from serum; Valens, a tool that uses proteomics technologies to determine the full-length amino acid sequence of a monoclonal antibody; and Reptor, an antibody repertoire sequencing and analysis tool.